1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global Graft versus Host Disease (GVHD) Market 2017-2027

Global Graft versus Host Disease (GVHD) Market 2017-2027

  • February 2017
  • 162 pages
  • ID: 4810651
  • Format: PDF
  • By Visiongain

Summary

Table of Contents

Report Details
The global graft versus host disease market is expected to grow at a CAGR of 7% from 2016-2021 and CAGR of 3% from 2021-2027. The market is expected to grow at a CAGR of 6% from 2016 to 2027. The market is estimated at $0.36bn in 2016, $0.51bn in 2021, and $0.64bn in 2026.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 162-page report you will receive 62 tables and 76 figures – all unavailable elsewhere.

The 162-page report provides clear detailed insight into the Graft versus Host Disease market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

- Revenue and growth forecasts to 2027 for the global GVHD market

- Revenue and growth forecasts to 2027 for the leading countries

- GVHD patient number forecast to 2027 per leading country, segmented into total allogenic cases, first allogenic cases, acute GVHD and chronic GVHD

- Revenue and growth forecasts to 2027 for the leading segments of the GVHD market by treatment type

- Revenue and growth forecasts to 2027 for the leading drugs in the GVHD market.

Individual revenue forecasts to 2027 by treatment type:
- Prophylaxis GVHD
- Chronic GVHD
- Acute GVHD

Individual revenue forecasts to 2027 by product:

- Corticosteroids
- Methylprednisolone
- Budenofalk (effeverscent)

- ATG therapies
- Available ATG therapy (Thymoglobulin)
- Atege-Fresenius

- IL2R? (CD25) inhibitors
- Simulect (Basiliximab)
- Leukotac (inolimomab)

- TNF? inhibitors
- Remicade (Infliximab)
- Enbrel (Etanercept)
- Co-stimulatory blockers
- Orencia (abatacept)
- Nulojix (belatacept)

- Other biologics
- Lemtrada (Alemtuzumab)
- Rituxan/MabThera (rituximab)
- Begedina (bt/9 anti-CD26)

- Calcineurin inhibitors
- Cyclosporine

- mTOR inhibitors
- Rapamune (sirolimus)
- Certican (everolimus)

- SOT therapies
- CellCept/Myfortic (mycophenolate mofetil)
- Prograf (tacrolimus)

- Anti-neoplastic therapies
- Velcade (bortezomib)
- Gleevec (imatinib)
- Methrotrexate
- Nipent (pentostatin)
- Cyclophosphamide

- Stem Cell Treatments
- In situ preparations of mesenchymal cells
- Prochymal (remestemcel-L)

- Extracorporeal Photophoresis
- Uvadex (Therakos)

Individual revenue forecasts to 2027 by country, further segmented by treatment type and by product:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan

GVHD patient number forecasts to 2027 per leading country, segmented into:
- total allogenic cases
- first allogenic cases
- acute GVHD
- chronic GVHD

Visiongain’s study is intended for anyone requiring commercial analyses for the GVHD market. You find data, trends and predictions.

Buy our report today Global Graft versus Host Disease (GVHD) Market 2017-2027: Acute, Chronic and Prophylaxis GVHD.

visiongain is a trading partner with the US Federal Government

Please note: This report is accessed through a password system. Single user (non-printable) and departmental licenses expires after 12 month period.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
2020 Fibrinogen Testing Market: USA, Europe, Japan--Competitive Strategies, Country Forecasts, Innovative technologies and Instrumentation

2020 Fibrinogen Testing Market: USA, Europe, Japan--Competitive Strategies, Country Forecasts, Innovative technologies and Instrumentation

  • $ 2500
  • January 2020

2020 Fibrinogen Testing Market: USA, Europe, Japan--Competitive Strategies, Country Forecasts, Innovative technologies and InstrumentationThe growing cost-containment pressures in major industrialized ...

Infection Control Market by Type and Geography - Forecast and Analysis 2020-2024

Infection Control Market by Type and Geography - Forecast and Analysis 2020-2024

  • $ 2500
  • November 2019

Global Infection Control Market: About this marketThis infection control market analysis considers sales from both therapeutic and non-therapeutic types. Our study also finds the sales of infection control ...

Europe Medical Equipment Maintenance Market to 2027 - Regional Analysis and Forecasts By Device Type ; Service Type ; Service Provider and Country

Europe Medical Equipment Maintenance Market to 2027 - Regional Analysis and Forecasts By Device Type ; Service Type ; Service Provider and Country

  • $ 3000
  • January 2020

The Europe medical equipment maintenance market is anticipated to reach US$ 9,953.13 Mn in 2027 from US$ 4,740.94 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027.The medical ...

Wounds - Pipeline Review, H2 2019 $ 2000 December 2019


ref:plp2017

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on